Biblio
Outcomes of allogeneic stem cell transplantation for patients with hematologic diseases ≥60 years old. Blood Cell Ther. 2023;6(2):30-41.
. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell. Exp Hematol. 2014.